Electrical impedance tomography in pulmonary arterial hypertension

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.16, n.3, article ID e0248214, 13p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The characterization of pulmonary arterial hypertension (PAH) relies mainly on right heart catheterization (RHC). Electrical impedance tomography (EIT) provides a non-invasive estimation of lung perfusion that could complement the hemodynamic information from RHC. To assess the association between impedance variation of lung perfusion (Delta Z(Q)) and hemodynamic profile, severity, and prognosis, suspected of PAH or worsening PAH patients were submitted simultaneously to RHC and EIT. Measurements of Delta Z(Q) were obtained. Based on the results of the RHC, 35 patients composed the PAH group, and eight patients, the normopressoric (NP) group. PAH patients showed a significantly reduced Delta Z(Q) compared to the NP group. There was a significant correlation between Delta Z(Q) and hemodynamic parameters, particularly with stroke volume (SV) (r = 0.76; P < 0.001). At 60 months, 15 patients died (43%) and 1 received lung transplantation; at baseline they had worse hemodynamics, and reduced Delta Z(Q) when compared to survivors. Patients with low Delta Z(Q) (<= 154.6%.Kg) presented significantly worse survival (P = 0.033). Delta Z(Q) is associated with hemodynamic status of PAH patients, with disease severity and survival, demonstrating EIT as a promising tool for monitoring patients with pulmonary vascular disease.
Palavras-chave
Referências
  1. Alves JL, 2015, CHEST, V147, P495, DOI 10.1378/chest.14-1036
  2. Bachmann MC, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2195-6
  3. Borges JB, 2012, J APPL PHYSIOL, V112, P225, DOI 10.1152/japplphysiol.01090.2010
  4. Boucly A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00279-2018
  5. Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017
  6. Braun F, 2020, J CLIN MONIT COMPUT, V34, P903, DOI 10.1007/s10877-019-00402-z
  7. Braun F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191870
  8. Costa ELV, 2005, VASC PHARMACOL, V43, P143, DOI 10.1016/j.vph.2005.05.004
  9. Costa ELV., 2013, CLIN PULM MED, V20, P178
  10. Ramos FJD, 2018, ANESTH ANALG, V126, P102, DOI 10.1213/ANE.0000000000002271
  11. Delcroix M, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00248-2018
  12. Eyuboglu B M, 1987, Clin Phys Physiol Meas, V8 Suppl A, P167, DOI 10.1088/0143-0815/8/4A/021
  13. Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC
  14. Frerichs I, 2007, PHYSIOL MEAS, V28, pS261, DOI 10.1088/0967-3334/28/7/S19
  15. Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075
  16. Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
  17. Gavilanes F, 2014, J BRAS PNEUMOL, V40, P609, DOI 10.1590/S1806-37132014000600004
  18. Hellige G, 2011, CRIT CARE, V15, DOI 10.1186/cc10231
  19. Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3
  20. Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029
  21. Humbert M, 2011, CHEST, V139, P1263, DOI 10.1378/chest.10-2868
  22. Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC
  23. Proenca M, 2014, IEEE T BIOMED CIRCUI, V8, P605
  24. Proenca M, 2016, PHYSIOL MEAS, V37, P713, DOI 10.1088/0967-3334/37/6/713
  25. Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x
  26. Smit HJ, 2006, RESPIRATION, V73, P597, DOI 10.1159/000088694
  27. Smit HJ, 2004, EUR J APPL PHYSIOL, V92, P45, DOI 10.1007/s00421-004-1043-3
  28. Smit HJ, 2002, PHYSIOL MEAS, V23, P237, DOI 10.1088/0967-3334/23/1/324
  29. Tanaka H, 2008, CLINICS, V63, P363, DOI 10.1590/S1807-59322008000300013
  30. van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477
  31. Vonk-Noordegraaf A, 2012, AM J CARDIOL, V110, p25S, DOI 10.1016/j.amjcard.2012.06.013
  32. Weatherald J, 2018, CIRCULATION, V137, P693, DOI 10.1161/CIRCULATIONAHA.117.029254
  33. Whyte K, 2012, EUR RESPIR J, V39, P313, DOI 10.1183/09031936.00019911